![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 12")
Endocannabinoid System Clinical Research: 2024 RCT Finds
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during a high-risk transition period. The study evaluated whether this digital tool…
endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image and disordered eating contribute to mental health and substance use outcomes in early adulthood. Findings from this cohort…
endocannabinoid system clinical research: Minder RCT
Clinical Takeaway A mobile app called Minder, co-developed with university students, was tested in a randomized controlled trial to evaluate its impact on mental health and substance use outcomes in a general college population. Digital tools like this…
`Cannabinoid Clinical Trials: Cannabis in Student Mental Health`
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the high-risk college transition period. Digital tools like this are being…
Endocannabinoid System Research: Trauma, Sleep & Cannabis Use
Clinical Takeaway Insomnia symptoms present before a traumatic event may increase the risk of alcohol and cannabis use in the weeks and months that follow, potentially through their influence on early posttraumatic stress symptoms. Clinicians treating…
`Endocannabinoid System & Adolescent Health: 15-Year REAL 2.0 Study`
Clinical Takeaway A 15-year Canadian cohort study tracked adolescents into early adulthood to examine how body image concerns and disordered eating in youth predict later eating disorders, mental health conditions, and substance use. The findings…
Endocannabinoid System & Trauma Sleep Research Findings
Clinical Takeaway Insomnia before a traumatic event increases the risk of developing posttraumatic stress symptoms, which in turn drives higher rates of alcohol and cannabis use in the weeks and months following trauma. Clinicians treating trauma…
endocannabinoid system clinical research: Eating & Weight
Clinical Takeaway A 15-year Canadian cohort study tracked adolescents into early adulthood to examine how body image concerns and disordered eating patterns in youth predict later eating disorders, mental health conditions, and substance use problems.…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Clinical Takeaway Adolescents with depression and anxiety symptoms show increased likelihood of initiating and escalating cannabis use over time, suggesting internalising disorders may drive substance use as a coping mechanism. Clinicians working with…
Adolescent Cannabis Use and Psychotic Disorder Risk
Clinical Takeaway Adolescent cannabis use is associated with increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large population-level longitudinal data tracking clinically…